Clinical Trials
All Clinical Trials - Page 3 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07756359Phase 4Not Yet Recruiting
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Tirzepatide
- NCT07811895N/ANot Yet Recruiting
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
Tirzepatide
- NCT07617155Phase 4Not Yet Recruiting
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
Semaglutide
- NCT07509112Phase 2Not Yet Recruiting
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Semaglutide
- NCT07628985Phase 3Not Yet Recruiting
BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes
Semaglutide
- NCT07677995N/AEnrolling By Invitation
Free Fatty Acid Effects In Type 2 Diabetes
Semaglutide
- NCT07668336Phase 3Not Yet Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Dulaglutide
- NCT07780344N/ANot Yet Recruiting
MRI Parameters as Biomarkers in Cystic Fibrosis (FEMPTO)
Linaclotide
- NCT06881888Phase 1Not Yet Recruiting
Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema
Octreotide
- NCT07743983Phase 3Recruiting
A Study of BGM0504 in Early T2DM With Obesity
Semaglutide
- NCT07780721Phase 2Not Yet Recruiting
Study of Adebrelimab Combined With Thymalfasin and Chemotherapy for Neoadjuvant Treatment of Esophageal Cancer
Thymosin-Alpha-1
- NCT07765160Phase 1Not Yet Recruiting
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Participants
Mazdutide
- NCT07747805Phase 2Not Yet Recruiting
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Tirzepatide
- NCT07751133Phase 3Recruiting
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Gonadorelin
- NCT07842640Phase 1Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight
Tirzepatide
- NCT07357740Phase 2Withdrawn
A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
Semaglutide
- NCT07794579Phase 3Recruiting
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Orforglipron
- NCT07191873Phase 4Recruiting
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide
- NCT07754461Phase 3Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Survodutide
- NCT07781371N/AActive Not Recruiting
A Retrospective Real-World Cohort Study
Semaglutide
- NCT07776977N/ARecruiting
Bedtime Device Restriction and Desmopressin in PMNE.
Desmopressin
- NCT07693608Phase 2Enrolling By Invitation
An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
Tirzepatide
- NCT07720466N/ANot Yet Recruiting
Salivary Function and Dental Changes During GLP-1 Therapy
Tirzepatide
- NCT06732245Phase 2Not Yet Recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
Tirzepatide
- NCT07728318N/ANot Yet Recruiting
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Tirzepatide
- NCT07767175Phase 1Recruiting
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Semaglutide
- NCT07563699Phase 1/Phase 2Recruiting
Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
Semaglutide
- NCT07760532N/ANot Yet Recruiting
Comparing Facial Aging Between Identical Twins With 3D Imaging
Tirzepatide
- NCT07554638Phase 4Recruiting
Incretin Therapies in Obesity-related HFpEF
Tirzepatide
- NCT07213323N/ARecruiting
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment
Tirzepatide
- NCT07745504Phase 3Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Semaglutide
- NCT07282613Phase 3Recruiting
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Semaglutide
- NCT07757087Phase 1Recruiting
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo
Amycretin
- NCT07676331Phase 2Not Yet Recruiting
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
Tirzepatide
- NCT07671248Phase 3Not Yet Recruiting
Tirzepatide in the Treatment of Cannabis Use Disorder
Tirzepatide
- NCT07630454Phase 4Not Yet Recruiting
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
Tirzepatide
- NCT07619989N/ARecruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
Tirzepatide
- NCT07592546Phase 4Not Yet Recruiting
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
Semaglutide
- NCT07179991N/ARecruiting
DDAVP Effect by TEG6 in Cardiac Surgery
Desmopressin
- NCT07298915Phase 3Not Yet Recruiting
The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
Tirzepatide
- NCT07668765N/ANot Yet Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Tirzepatide
- NCT07671391Phase 2Not Yet Recruiting
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
Tirzepatide
- NCT07684144Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Maridebart-Cafraglutide
- NCT07218354Phase 3Recruiting
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
Semaglutide
- NCT07573163Phase 2Recruiting
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide
- NCT07588438Phase 4Recruiting
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Tirzepatide
- NCT07684235Phase 3Recruiting
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Maridebart-Cafraglutide
- NCT07496463Phase 2Enrolling By Invitation
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
Setmelanotide
- NCT07697391Phase 4Not Yet Recruiting
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
Tirzepatide
- NCT07728669N/ARecruiting
Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy
Semaglutide